GSK, Sanofi begin new Covid-19 vaccine trial of protein-based vaccine | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
June 21, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, JUNE 21, 2025
GSK, Sanofi begin new Covid-19 vaccine trial of protein-based vaccine

Coronavirus chronicle

Reuters
22 February, 2021, 05:10 pm
Last modified: 22 February, 2021, 05:12 pm

Related News

  • Novavax signs Covid-19 license deal with Sanofi, removes doubt about business viability
  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • GSK licenses companies to make cheap copies of HIV prevention drug
  • Incepta Pharma abandons Covid vaccine plan

GSK, Sanofi begin new Covid-19 vaccine trial of protein-based vaccine

The move comes after the drugmakers in December said their vaccine would be delayed after clinical trials showed an insufficient immune response in older people

Reuters
22 February, 2021, 05:10 pm
Last modified: 22 February, 2021, 05:12 pm
Photo: Collected
Photo: Collected

Britain's GlaxoSmithKline and France's Sanofi on Monday said they had started a new clinical trial of their protein-based Covid-19 vaccine candidate and aim to reach the final testing stage in the second quarter.

The move comes after the drugmakers in December said their vaccine would be delayed after clinical trials showed an insufficient immune response in older people.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Top News

Sanofi / GSK / covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Foreign Affairs Adviser Md Touhid Hossain speaks at the 51st Session of the Council of Foreign Ministers of the Organisation of Islamic Cooperation (OIC) in Istanbul, Turkey on 21 June 2025. Photo: Courtesy
    Bangladesh urges global community to hold Israel accountable for its actions
  • Protesting NBR officials hold a press briefing in Agargaon, Dhaka on 18 May 2025. Photo: TBS
    NBR Reform Unity Council announces fresh round of pen-down strike for Monday to press demands
  • The Organization of Islamic Cooperation (OIC) Council of Foreign Ministers convened in Istanbul on Saturday. Photo: Collected
    OIC foreign ministers condemn Israeli aggression, call for regional unity

MOST VIEWED

  • BUET Professor Md Ehsan stands beside his newly designed autorickshaw—just 3.2 metres long and 1.5 metres wide—built for two passengers to ensure greater stability and prevent tipping. With a safety-focused top speed of 30 km/h, the vehicle can be produced at an estimated cost of Tk1.5 lakh. Photo: Junayet Rashel
    Buet’s smart fix for Dhaka's autorickshaws
  • Collage of the two Shahjalal University of Science and Technology (SUST) students -- Swagata Das Partha (left) and Shanto Tara Adnan (right) -- who have been arrested over raping a classmate after rendering her unconscious and filming nude videos. Photos: Collected
    2 SUST students held for allegedly rendering female classmate unconscious, raping her, filming nude videos
  • File photo of containers at Chattogram port/TBS
    3-month interim extension sought for Saif Powertec to operate Ctg port terminal
  • Photo: Collected
    All BTS members officially complete military service as Suga gets discharged
  • Dhaka Medical College students demonstrate over five demands in front of the institution's main gate in Dhaka on 21 June 2025. Photo: Courtesy
    Dhaka Medical College closed indefinitely amid protests over accommodation, students ordered to vacate halls
  • Infographic: TBS
    Airlines struggle to acquire planes amid global supply shortage

Related News

  • Novavax signs Covid-19 license deal with Sanofi, removes doubt about business viability
  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • GSK licenses companies to make cheap copies of HIV prevention drug
  • Incepta Pharma abandons Covid vaccine plan

Features

Illustration: TBS

Examophobia tearing apart Bangladesh’s education system

5m | Panorama
Airmen look at a GBU-57, or Massive Ordnance Penetrator bomb, at Whiteman Air Force Base in Missouri, US in 2023. Photo: Collected

Is the US preparing for direct military action in Iran?

11h | Panorama
Monsoon in Bandarban’s hilly hiking trails means endless adventure — something hundreds of Bangladeshi hikers eagerly await each year. But the risks are sometimes not worth the reward. Photo: Collected

Tragedy on the trail: The deadly cost of unregulated adventure tourism in Bangladesh’s hills

1d | Panorama
BUET Professor Md Ehsan stands beside his newly designed autorickshaw—just 3.2 metres long and 1.5 metres wide—built for two passengers to ensure greater stability and prevent tipping. With a safety-focused top speed of 30 km/h, the vehicle can be produced at an estimated cost of Tk1.5 lakh. Photo: Junayet Rashel

Buet’s smart fix for Dhaka's autorickshaws

1d | Features

More Videos from TBS

No chance of postponing LDC graduation: Commerce Secretary

No chance of postponing LDC graduation: Commerce Secretary

15m | TBS Today
The budget has put too much pressure on the private sector: Shamim Ehsan

The budget has put too much pressure on the private sector: Shamim Ehsan

35m | TBS Today
Bangladesh not ready for LDC graduation: Rubana Haque

Bangladesh not ready for LDC graduation: Rubana Haque

1h | TBS Today
What does the planning advisor say about the budget and LDC graduation?

What does the planning advisor say about the budget and LDC graduation?

1h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net